Literature DB >> 10027105

Risk of HCV infections among children with cancer and health-care workers in children's hospitals.

J Styczynski1, S Koltan, M Wysocki, R Graczykowski, E Narolska, A Balcar-Boron.   

Abstract

After the outbreak of an endemy of HCV infections in the paediatric haematology and oncology wards, epidemiological analysis was performed for cancer children, health-care workers and controls. The study included a total of 639 persons, divided into four groups. The results were as follows: 1) The number of infected paediatric cancer patients was 100/237 (42.4%). 2) Of the 44 health-care workers in the haemato-oncology ward none was infected with HCV. 3) In the other parts of the hospital, five out of 258 (1.9%) permanently employed staff at risk of occupational exposure to blood and other body fluids were infected with HCV; however, the infection rate included only nurses (5/125, i.e. 4%). 4) One hundred adults consecutively tested for anti-HCV antibodies before a planned surgical procedure were not infected with HCV (control group). This study shows that complex nonspecific prophylaxis and full awareness in everyday work has helped to prevent transmission of HCV from highly contagious patients to medical personnel, particularly to nurses who have the highest occupational risk.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10027105     DOI: 10.1007/bf02565169

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  10 in total

1.  Low prevalence of antibodies to hepatitis C virus in hospital employees.

Authors:  E Francavilla; R Rinaldi; A M Cattelan; M Vicariotto; F Bortolotti; P Cadrobbi
Journal:  Infection       Date:  1992 Sep-Oct       Impact factor: 3.553

2.  Prevalence of hepatitis C infection in health care workers affiliated with a liver transplant center.

Authors:  A M Goetz; O K Ndimbie; M M Wagener; R R Muder
Journal:  Transplantation       Date:  1995-04-15       Impact factor: 4.939

3.  Occupational risk for hepatitis C virus infection among New York City dentists.

Authors:  R S Klein; K Freeman; P E Taylor; C E Stevens
Journal:  Lancet       Date:  1991 Dec 21-28       Impact factor: 79.321

4.  Prevalence of HCV antibodies in health-care workers from northern Italy.

Authors:  C Campello; S Majori; A Poli; P Pacini; L Nicolardi; F Pini
Journal:  Infection       Date:  1992 Jul-Aug       Impact factor: 3.553

5.  Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection.

Authors:  D L Thomas; S H Factor; G D Kelen; A S Washington; E Taylor; T C Quinn
Journal:  Arch Intern Med       Date:  1993-07-26

6.  Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward.

Authors:  T Allander; A Gruber; M Naghavi; A Beyene; T Söderström; M Björkholm; L Grillner; M A Persson
Journal:  Lancet       Date:  1995-03-11       Impact factor: 79.321

7.  Prevalence of antibodies to hepatitis C virus in transfused children with cancer.

Authors:  P M Monteleone; C Andrzejewski; J F Kelleher
Journal:  Am J Pediatr Hematol Oncol       Date:  1994-11

8.  Prevalence of antibodies against hepatitis C virus infection among health care workers in Stockholm.

Authors:  J Struve; B Aronsson; B Frenning; M Forsgren; O Weiland
Journal:  Scand J Gastroenterol       Date:  1994-04       Impact factor: 2.423

9.  Hepatitis C virus infection in children treated for acute lymphoblastic leukemia.

Authors:  M Aricò; G Maggiore; E Silini; F Bono; C Viganò; A Cerino; M U Mondelli
Journal:  Blood       Date:  1994-11-01       Impact factor: 22.113

10.  Prevalence of hepatitis C antibodies in clinical health-care workers.

Authors:  J Zuckerman; G Clewley; P Griffiths; A Cockcroft
Journal:  Lancet       Date:  1994-06-25       Impact factor: 79.321

  10 in total
  1 in total

1.  Use of the minimum spanning tree model for molecular epidemiological investigation of a nosocomial outbreak of hepatitis C virus infection.

Authors:  Enea Spada; Luciano Sagliocca; John Sourdis; Anna Rosa Garbuglia; Vincenzo Poggi; Carmela De Fusco; Alfonso Mele
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.